Pharmafile Logo
Pharmafocus logo
Advanced Search

MHRA

Showing 15 posts of 106 posts found.

Entresto

Novartis heart failure drug available via EAMS

September 3, 2015
Sales and Marketing Early Access to Medicines Scheme, Entresto, LCZ696, MHRA, Novartis, eams, heart failure, sacubitril/valsartan

Novartis has won the investigational heart failure treatment LCZ696 (sacubitril valsartan) will be available in the UK under the Early …

News

Opdivo launched in the UK for skin cancer

July 2, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer

Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …

News
Fake drugs image

£15.8 million UK haul of fake drugs

June 19, 2015
Manufacturing and Production, Sales and Marketing MHRA, counterfeit, drugs, fake, interpol

Counterfeit and unlicensed medicines and devices worth £15.8 million have been seized in the UK as part of a global …

News
Novartis image

Novartis heart drug steps closer to EAMS scheme

April 23, 2015
Sales and Marketing LCZ696, MHRA, Medicines and Healthcare products Regulatory Agency, NICE, eams, pim, sacubitril/valsartan

Novartis’ investigational heart failure drug LCZ696 has been handed a Promising Innovative Medicine designation (PIM) after showing that it significantly …

News

Novartis in major oncology drive

March 30, 2015
Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia

Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …

News
Champix image

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015
Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

News
screen_shot_2015-02-20_at_14

Chair appointed for new MHRA devices committee

February 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, Peter Nightingale, deac

Dr Peter Nightingale has been appointed as chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) newly-formed Devices Expert …

Appointment
MHRA image

Websites selling illegal drugs increasingly face closure

February 12, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, counterfeit, drugs, illegal, on tap, websites

The number of websites shut down by the MHRA for selling illegal pharmaceutical products has increased dramatically in recent years, …

News
Manufacturing image

MHRA shuts down unlicensed cancer drug facility

February 9, 2015
Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor

The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …

News
23andme image

Genentech makes $10m gene testing outlay

January 8, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …

News
janet_valentine

MRC head joins CPRD as director

January 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, MRC, cprd, janet valentine

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an appointment of a new director for The Clinical Practice …

Appointment

Chiesi gets first-ever European stem cell nod

December 19, 2014
Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …

News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014
Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …

News
23andMe genome testing kit image

MHRA approves Google gene test for UK

December 2, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, FDA, MHRA, UK, US, gene, google, test

The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …

News
Rawlins image

Sir Michael Rawlins appointed chair of MHRA

November 4, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins

The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026